Browsing by Subject
Ara mostrant els elements 1-20 d 24
-
Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer
(Frontiers Media, 2021-09) -
Epstein–Barr Virus+ B Cells in Breast Cancer Immune Response: A Case Report
(Frontiers Media, 2021-11) -
Evaluation of triple negative breast cancer with heterogeneous immune infiltration
(Frontiers Media, 2023-05-04) -
Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer
(American Association for Cancer Research, 2022-03-01) -
Genetic and functional homologous repair deficiency as biomarkers for platinum sensitivity in TNBC: A case report
(Frontiers Media, 2022-09-14) -
Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer
(AME Publishing Company, 2020-07) -
Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer
(American Society of Clinical Oncology, 2023-12-01) -
Immunotherapy for early triple negative breast cancer: research agenda for the next decade
(Nature Research, 2022-02-18) -
Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer
(EMBO Press, 2023-12-07) -
LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells
(Springer Nature, 2020-01-02) -
MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer
(Wiley, 2023-01-11) -
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
(American Association for Cancer Research, 2023-12-01)